Balance Sheet MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Real-time Euronext Paris Other stock markets 11:35:27 2026-01-21 am EST			5-day change	1st Jan Change
27.74 ^EUR	+2.51%		+0.58%	+10.08%

Dec. 10	Medincell Narrows Operating Loss in First Half
Dec. 10	MedinCell Says Partner Filed US FDA Application for Once-monthly Schizophrenia Treatment	MT

9cfc27598.aOJHbF0qbpTKc2Osep8ofILr8NWIRN6i_rfq1SmoYqg.UbIgBgJJHeKTAg3DSNRdNfCyhuzEC-fxk-Skl0eZVuYnoR1cEB8E-4krAA

Published financial data: MEDINCELL S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	8.19M	4.09M	9.89M	9.03M	25.42M
Other Revenues, Total	3.59M	1K	3.77M	2.91M	2.31M
Total Revenues	11.78M	4.09M	13.66M	11.94M	27.73M
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	11.78M	4.09M	13.66M	11.94M	27.73M
Selling General & Admin Expenses, Total	7.58M	8.49M	9.72M	11.79M	14.18M
R&D Expenses	19.56M	23.58M	27.92M	21.05M	24.31M
Other Operating Expenses	5K	81K	44K	40K	-
Other Operating Expenses, Total	27.14M	32.15M	37.68M	32.88M	38.49M
Operating Income	-15.37M	-28.06M	-24.02M	-20.94M	-10.76M
Interest Expense, Total	-3.58M	-1.84M	-3.93M	-4.62M	-5.09M
Interest And Investment Income	40K	46K	41K	553K	1.4M
Net Interest Expenses	-3.54M	-1.8M	-3.89M	-4.06M	-3.69M
Currency Exchange Gains (Loss)	-226K	829K	1.17M	135K	-230K
Other Non Operating Income (Expenses)	356K	-23K	-5.2M	-44K	-3.52M
EBT, Excl. Unusual Items	-18.78M	-29.05M	-31.95M	-24.91M	-18.2M
Gain (Loss) On Sale Of Investments	-	-	-37K	-	-
Gain (Loss) On Sale Of Assets	-	3K	-	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-239K	4.24M	-21K	-37K	-78K
EBT, Incl. Unusual Items	-19.02M	-24.81M	-32.01M	-24.95M	-18.28M
Income Tax Expense	-	-	-	88K	160K
Earnings From Continuing Operations	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Net Income to Company	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Net Income to Common Incl Extra Items	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Net Income to Common Excl. Extra Items	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Per Share Items
Net EPS - Basic	-0.86	-1	-1.27	-0.88	-0.62
Basic EPS - Continuing Operations	-0.86	-1	-1.27	-0.88	-0.62
Basic Weighted Average Shares Outstanding	22.04M	24.84M	25.15M	28.42M	29.64M
Net EPS - Diluted	-0.86	-1	-1.27	-0.88	-0.62
Diluted EPS - Continuing Operations	-0.86	-1	-1.27	-0.88	-0.62
Diluted Weighted Average Shares Outstanding	22.04M	24.84M	25.15M	28.42M	29.64M
Normalized Basic EPS	-0.53	-0.73	-0.79	-0.55	-0.38
Normalized Diluted EPS	-0.53	-0.73	-0.79	-0.55	-0.38
Supplemental Items
EBITDA	-14.56M	-27.2M	-23.05M	-20.05M	-10.07M
EBITA	-15.37M	-28.06M	-24.02M	-20.94M	-10.76M
EBIT	-15.37M	-28.06M	-24.02M	-20.94M	-10.76M
EBITDAR	-	-	-22.33M	-19.98M	-10.01M
Total Revenues (As Reported)	11.78M	8.34M	13.66M	11.94M	27.73M
Effective Tax Rate - (Ratio)	-	-	-	-0.35	-0.88
Total Current Taxes	-	-	-	88K	160K
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-11.74M	-18.16M	-19.97M	-15.57M	-11.38M
Interest on Long-Term Debt	800K	100K	35K	4.51M	5.06M
Non-Cash Pension Expense	-23K	-11K	-5K	5K	-3K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	-	-	-	2.31M	-
Selling and Marketing Expenses	1.8M	2.27M	2.59M	2.64M	3.26M
General and Administrative Expenses	5.78M	6.21M	7.13M	9.15M	10.92M
Research And Development Expense From Footnotes	19.61M	23.61M	27.92M	21.08M	24.32M
Net Rental Expense, Total	-	-	720K	65K	65K
Imputed Operating Lease Interest Expense	-	-	431K	39.22K	40.08K
Imputed Operating Lease Depreciation	-	-	289K	25.78K	24.92K
Stock-Based Comp., R&D Exp. (Total)	1.12M	1.59M	1.41M	1.72M	-
Stock-Based Comp., S&M Exp. (Total)	125K	322K	268K	332K	343K
Stock-Based Comp., G&A Exp. (Total)	318K	485K	601K	760K	-
Stock-Based Comp., Other (Total)	-	-	-	-	2.62M
Total Stock-Based Compensation	1.56M	2.39M	2.28M	2.81M	2.96M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	47.1M	24.62M	6.47M	19.46M	59.04M
Short Term Investments	2.79M	1.97M	3K	-	12.86M
Total Cash And Short Term Investments	49.88M	26.59M	6.47M	19.46M	71.9M
Accounts Receivable, Total	883K	799K	2.09M	2.25M	3.15M
Other Receivables	3.71M	4.88M	10.18M	4.46M	4.52M
Total Receivables	4.59M	5.68M	12.27M	6.71M	7.67M
Inventory	-	-	-	-	-
Prepaid Expenses	865K	1.14M	744K	966K	941K
Other Current Assets, Total	986K	665K	82K	118K	110K
Total Current Assets	56.32M	34.07M	19.57M	27.26M	80.62M
Gross Property Plant And Equipment	6.91M	10.87M	11M	10.83M	11.28M
Accumulated Depreciation	-3.06M	-3.84M	-4.63M	-5.4M	-6.01M
Net Property Plant And Equipment	3.85M	7.03M	6.37M	5.43M	5.27M
Long-term Investments	1.08M	1.27M	902K	21K	21K
Other Intangibles, Total	1.49M	1.67M	1.92M	2.45M	2.65M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	859K	259K	572K	1.79M	1.89M
Total Assets	63.61M	44.3M	29.34M	36.95M	90.45M
Liabilities
Accounts Payable, Total	2.96M	2.98M	4.18M	1.85M	4M
Accrued Expenses, Total	1.96M	1.42M	2.48M	3.15M	5.07M
Current Portion of Long-Term Debt	3.18M	27.76M	42.81M	5.52M	6.62M
Current Portion of Leases	390K	581K	643K	643K	673K
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	4.85M	5.29M	5.78M	5.18M	13.38M
Other Current Liabilities	265K	210K	1.13M	129K	133K
Total Current Liabilities	13.6M	38.24M	57.02M	16.47M	29.87M
Long-Term Debt	39.07M	16.25M	11.71M	56.29M	57.98M
Long-Term Leases	705K	2.9M	2.54M	2.26M	2.05M
Unearned Revenue Non Current	840K	-	-	-	13.4M
Pension & Other Post Retirement Benefits	451K	265K	354K	365K	361K
Other Non Current Liabilities	23K	22K	2K	2.4M	3.16M
Total Liabilities	54.69M	57.67M	71.63M	77.77M	107M
Common Stock, Total	247K	251K	253K	291K	331K
Additional Paid In Capital	75.15M	6.91M	7.42M	31.01M	70.72M
Retained Earnings	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Comprehensive Income and Other	-47.46M	4.27M	-17.95M	-47.09M	-68.98M
Total Common Equity	8.92M	-13.37M	-42.29M	-40.82M	-16.37M
Minority Interest	-	-	-	-	-
Total Equity	8.92M	-13.37M	-42.29M	-40.82M	-16.37M
Total Liabilities And Equity	63.61M	44.3M	29.34M	36.95M	90.45M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	24.68M	25.11M	28.71M	29.09M	33.08M
ECS Total Common Shares Outstanding	24.68M	25.11M	25.28M	29.07M	33.07M
Book Value / Share	0.36	-0.53	-1.67	-1.4	-0.49
Tangible Book Value	7.43M	-15.04M	-44.22M	-43.27M	-19.01M
Tangible Book Value Per Share	0.3	-0.6	-1.75	-1.49	-0.58
Total Debt	43.34M	47.49M	57.71M	64.71M	67.32M
Net Debt	-6.54M	20.9M	51.24M	45.25M	-4.58M
Debt Equivalent of Unfunded Proj. Benefit Obligation	451K	265K	354K	365K	361K
Debt Equivalent Oper. Leases	-	-	5.76M	520K	520K
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	13K	14K	15K	15K	15K
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	5.69M	7.14M	7.36M	7.64M	8.28M
Full Time Employees	138	139	131	134	131
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-19.02M	-24.81M	-32.01M	-25.04M	-18.44M
Depreciation & Amortization - CF	1.14M	1.36M	1.5M	1.52M	1.38M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	1.14M	1.36M	1.5M	1.52M	1.38M
Amortization of Deferred Charges, Total - (CF)	196K	161K	166K	197K	609K
(Gain) Loss From Sale Of Asset	-	-3K	33K	296K	156K
Stock-Based Compensation (CF)	1.56M	2.39M	2.28M	2.81M	2.96M
Other Operating Activities, Total	3.36M	1.9M	10.06M	5.11M	8.26M
Change In Accounts Receivable	-264K	84K	-1.29M	-161K	-893K
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	-180K	26K	1.2M	-2.33M	2.15M
Change in Other Net Operating Assets	1.07M	-2.48M	-2.94M	5.67M	23.28M
Cash from Operations	-12.14M	-21.36M	-21M	-11.92M	19.46M
Capital Expenditure	-645K	-1.62M	-576K	-324K	-747K
Sale of Property, Plant, and Equipment	-	16K	48K	1K	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-174K	-351K	-451K	-867K	-913K
Investment in Marketable and Equity Securities, Total	-284K	1.55M	2.23M	24K	-12.95M
Other Investing Activities, Total	41K	95K	44K	553K	1.4M
Cash from Investing	-1.06M	-316K	1.3M	-613K	-13.21M
Long-Term Debt Issued, Total	18.71M	3.31M	29.98M	13.84M	-
Total Debt Issued	18.71M	3.31M	29.98M	13.84M	-
Long-Term Debt Repaid, Total	-9.57M	-2.84M	-24.77M	-9.46M	-4.81M
Total Debt Repaid	-9.57M	-2.84M	-24.77M	-9.46M	-4.81M
Issuance of Common Stock	42.28M	48K	810K	23.32M	43.29M
Repurchase of Common Stock	-	-192K	-	-25K	-
Other Financing Activities, Total	-3.5M	-1.13M	-4.46M	-2.15M	-5.15M
Cash from Financing	47.92M	-800K	1.56M	25.53M	33.32M
Miscellaneous Cash Flow Adjustments	-	-	1K	-	1K
Net Change in Cash	34.72M	-22.48M	-18.15M	12.99M	39.58M
Supplemental Items
Cash Interest Paid	3.5M	1.13M	4.46M	2.15M	1.7M
Cash Income Tax Paid (Refund)	-	-	-	-	160K
Levered Free Cash Flow	-5.65M	-17.93M	-16.5M	-10.6M	4.74M
Unlevered Free Cash Flow	-3.41M	-16.78M	-14.04M	-7.72M	7.92M
Change In Net Working Capital	-4.11M	1.18M	1.94M	-2.04M	-11.35M
Net Debt Issued / Repaid	9.14M	470K	5.21M	4.38M	-4.81M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-21.13	-32.5	-40.78	-39.49	-10.56
Return on Total Capital	-27.39	-40.5	-60.63	-66.61	-17.98
Return On Equity %	540.19	1.17K	115.01	60.25	64.48
Return on Common Equity	540.19	1.17K	115.01	60.25	64.48
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	64.33	207.43	71.15	98.72	51.13
EBITDA Margin %	-123.69	-664.78	-168.81	-167.82	-36.32
EBITA Margin %	-130.51	-685.87	-175.94	-175.3	-38.81
EBIT Margin %	-130.51	-685.87	-175.94	-175.3	-38.81
Income From Continuing Operations Margin %	-161.53	-606.36	-234.42	-209.61	-66.5
Net Income Margin %	-161.53	-606.36	-234.42	-209.61	-66.5
Net Avail. For Common Margin %	-161.53	-606.36	-234.42	-209.61	-66.5
Normalized Net Income Margin	-99.69	-443.82	-146.25	-130.35	-41.02
Levered Free Cash Flow Margin	-47.99	-438.24	-120.81	-88.75	17.09
Unlevered Free Cash Flow Margin	-28.98	-410.07	-102.82	-64.59	28.56
Asset Turnover
Asset Turnover	0.26	0.08	0.37	0.36	0.44
Fixed Assets Turnover	2.98	0.75	2.04	2.02	5.18
Receivables Turnover (Average Receivables)	10.89	4.86	6.84	4.16	9.41
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	4.14	0.89	0.34	1.66	2.7
Quick Ratio	4.01	0.84	0.33	1.59	2.66
Operating Cash Flow to Current Liabilities	-0.89	-0.56	-0.37	-0.72	0.65
Days Sales Outstanding (Average Receivables)	33.51	75.05	53.37	88.08	38.78
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	-	-	-	-
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	486.15	-355.18	-136.44	-158.5	-411.33
Total Debt / Total Capital	82.94	139.19	374.4	270.94	132.12
LT Debt/Equity	446.12	-143.19	-33.7	-143.41	-366.76
Long-Term Debt / Total Capital	76.11	56.11	92.47	245.14	117.81
Total Liabilities / Total Assets	85.98	130.18	244.16	210.49	118.09
EBIT / Interest Expense	-4.29	-15.22	-6.11	-4.54	-2.12
EBITDA / Interest Expense	-3.97	-14.48	-5.73	-4.21	-1.84
(EBITDA - Capex) / Interest Expense	-4.15	-15.36	-5.88	-4.28	-1.99
Total Debt / EBITDA	-3.05	-1.78	-2.56	-3.33	-7.18
Net Debt / EBITDA	0.46	-0.78	-2.27	-2.33	0.49
Total Debt / (EBITDA - Capex)	-2.91	-1.68	-2.5	-3.28	-6.65
Net Debt / (EBITDA - Capex)	0.44	-0.74	-2.22	-2.29	0.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	96.25	-50.02	63.77	-12.52	132.12
Gross Profit, 1 Yr. Growth %	96.25	-50.02	63.77	-12.52	132.12
EBITDA, 1 Yr. Growth %	-20.69	50.06	0.44	-13.04	-49.76
EBITA, 1 Yr. Growth %	-19.85	48.25	0.89	-12.84	-48.61
EBIT, 1 Yr. Growth %	-19.85	48.25	0.89	-12.84	-48.61
Earnings From Cont. Operations, 1 Yr. Growth %	-20.47	30.65	29.04	-21.78	-26.36
Net Income, 1 Yr. Growth %	-20.47	30.65	29.04	-21.78	-26.36
Normalized Net Income, 1 Yr. Growth %	-11.79	30.06	28.82	-22.03	-26.95
Diluted EPS Before Extra, 1 Yr. Growth %	-27.5	16.01	27.27	-30.67	-29.38
Accounts Receivable, 1 Yr. Growth %	42.42	-9.51	161.95	7.69	39.62
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-4.96	82.48	-9.37	-14.74	-2.94
Total Assets, 1 Yr. Growth %	132.93	-30.35	-33.78	25.93	144.81
Tangible Book Value, 1 Yr. Growth %	-142.54	-296.79	194.07	-2.14	-56.06
Common Equity, 1 Yr. Growth %	-155.87	-246.5	216.31	-3.48	-59.91
Cash From Operations, 1 Yr. Growth %	-3.21	76.05	-1.67	-43.24	-263.27
Capital Expenditures, 1 Yr. Growth %	12.17	151.63	-64.51	-43.75	130.56
Levered Free Cash Flow, 1 Yr. Growth %	-50.78	127.64	8.01	-35.74	-144.7
Unlevered Free Cash Flow, 1 Yr. Growth %	-66.42	197.64	-0.58	-45.04	-202.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	70.57	-17.43	29.15	19.69	42.5
Gross Profit, 2 Yr. CAGR %	72.26	-17.43	29.15	19.69	42.5
EBITDA, 2 Yr. CAGR %	-1.17	21.69	12.78	-6.54	-33.9
EBITA, 2 Yr. CAGR %	-0.45	20.97	12.67	-6.22	-33.07
EBIT, 2 Yr. CAGR %	-0.45	20.97	12.67	-6.22	-33.07
Earnings From Cont. Operations, 2 Yr. CAGR %	-1.7	1.85	29.85	0.47	-24.1
Net Income, 2 Yr. CAGR %	-1.71	1.85	29.85	0.47	-24.1
Normalized Net Income, 2 Yr. CAGR %	-0.96	16.81	19.6	0.22	-24.53
Diluted EPS Before Extra, 2 Yr. CAGR %	-13.03	-8.33	21.51	-6.14	-30.03
Accounts Receivable, 2 Yr. CAGR %	51.84	13.52	53.96	67.96	22.62
Net Property, Plant and Equip., 2 Yr. CAGR %	7.76	31.69	28.6	-12.1	-9.03
Total Assets, 2 Yr. CAGR %	29.41	27.37	-32.08	-8.68	75.58
Tangible Book Value, 2 Yr. CAGR %	24.45	-7.21	140.56	69.64	-34.43
Common Equity, 2 Yr. CAGR %	19.51	-8.46	115.27	74.73	-37.79
Cash From Operations, 2 Yr. CAGR %	-12.72	30.52	31.57	-25.29	-3.74
Capital Expenditures, 2 Yr. CAGR %	70.07	68.01	-5.5	-55.32	13.88
Levered Free Cash Flow, 2 Yr. CAGR %	-32.19	24.96	44.73	-16.69	-46.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.21	28.5	57.83	-26.08	-24.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.36	0.36	31.54	13.42	49.26
Gross Profit, 3 Yr. CAGR %	13.36	1.02	31.54	13.42	49.26
EBITDA, 3 Yr. CAGR %	31.03	22.17	7.87	3.42	-24.01
EBITA, 3 Yr. CAGR %	30.17	21.86	7.81	3.43	-23.26
EBIT, 3 Yr. CAGR %	30.17	21.86	7.81	3.43	-23.26
Earnings From Cont. Operations, 3 Yr. CAGR %	25.71	8.02	10.21	9.66	-9.42
Net Income, 3 Yr. CAGR %	25.72	8.01	10.21	9.66	-9.42
Normalized Net Income, 3 Yr. CAGR %	28.83	14.91	14.49	3.71	-9.8
Diluted EPS Before Extra, 3 Yr. CAGR %	9.17	-4.3	2.27	0.73	-14.63
Accounts Receivable, 3 Yr. CAGR %	106.01	27.78	50.01	36.67	57.92
Net Property, Plant and Equip., 3 Yr. CAGR %	12.24	28.44	16.27	12.14	-9.15
Total Assets, 3 Yr. CAGR %	35.88	5.27	2.42	-16.56	26.86
Tangible Book Value, 3 Yr. CAGR %	-18.65	46.35	36.3	78.25	8.14
Common Equity, 3 Yr. CAGR %	-8.87	28.9	38.39	64.76	6.97
Cash From Operations, 3 Yr. CAGR %	30.78	10.27	18.76	-0.59	-3.05
Capital Expenditures, 3 Yr. CAGR %	4.95	93.79	0.06	-20.51	-22.79
Levered Free Cash Flow, 3 Yr. CAGR %	4.77	13.41	12.84	10.41	-32.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.18	15.24	11.38	11.03	-17.54
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.88	-16.29	10.47	24.17	35.82
Gross Profit, 5 Yr. CAGR %	4.88	-14.72	11.06	24.66	35.82
EBITDA, 5 Yr. CAGR %	89.89	55.03	28.92	6.09	-11.32
EBITA, 5 Yr. CAGR %	105.34	52.54	28.09	6.19	-10.91
EBIT, 5 Yr. CAGR %	105.34	50.88	28.09	6.19	-10.91
Earnings From Cont. Operations, 5 Yr. CAGR %	100.64	47.63	27.3	4.93	-5.07
Net Income, 5 Yr. CAGR %	98.19	47.43	27.31	4.93	-5.07
Normalized Net Income, 5 Yr. CAGR %	117.12	42.61	29.47	5.41	-3.09
Diluted EPS Before Extra, 5 Yr. CAGR %	84.83	31.95	13.93	-5.04	-12.16
Accounts Receivable, 5 Yr. CAGR %	-16.35	-3.05	83.35	42.54	38.39
Net Property, Plant and Equip., 5 Yr. CAGR %	20.8	23.13	18.52	10.37	5.4
Total Assets, 5 Yr. CAGR %	41.6	13.75	2.96	-0.55	27.07
Tangible Book Value, 5 Yr. CAGR %	169.77	30.87	26.22	55.26	1.71
Common Equity, 5 Yr. CAGR %	48.37	41.8	29.12	45.58	0.51
Cash From Operations, 5 Yr. CAGR %	182.04	44.48	31.09	-5.63	9.19
Capital Expenditures, 5 Yr. CAGR %	-4.52	3.81	0.64	7.76	5.37
Levered Free Cash Flow, 5 Yr. CAGR %	-	28.48	27.41	-2.92	-16.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	31.26	30.15	-6.78	-4.86